By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
Surya Pharmaceutical Ltd.
BSE: 532516 | Sector: Health care |
NSE: SURYAPHARM | ISIN Code: INE249G01020 |
BSE 00:00 | 24 Feb | Surya Pharmaceutical Ltd |
NSE 05:30 | 01 Jan | Surya Pharmaceutical Ltd |
OPEN | 0.22 |
PREVIOUS CLOSE | 0.22 |
VOLUME | 241733 |
52-Week high | 0.23 |
52-Week low | 0.00 |
P/E | 0.02 |
Mkt Cap.(Rs cr) | 4 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.23 |
Sell Qty | 1.00 |
Surya Pharmaceutical Ltd. (SURYAPHARM) - Net Sales
Market Cap
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
Cipla | 543.10 | 2.05 | 0.38 | 11389.90 |
Aurobindo Pharma | 730.55 | 8.05 | 1.11 | 10269.90 |
Lupin | 770.05 | 9.35 | 1.23 | 10080.58 |
Dr Reddy's Labs | 2585.50 | 61.80 | 2.45 | 9359.30 |
Sun Pharma.Inds. | 429.75 | 7.55 | 1.79 | 7923.84 |
Apollo Hospitals | 1152.80 | 21.05 | 1.86 | 7183.01 |
Glenmark Pharma. | 586.90 | -0.05 | -0.01 | 6403.23 |
Cadila Health. | 313.25 | -0.35 | -0.11 | 5809.90 |
Alkem Lab | 1805.50 | -30.70 | -1.67 | 5300.26 |
Torrent Pharma. | 1767.95 | 1.80 | 0.10 | 4228.43 |
Divi's Lab. | 1549.90 | -11.85 | -0.76 | 3815.94 |
Jubilant Life | 751.25 | 2.80 | 0.37 | 3306.33 |
Abbott India | 7243.70 | -47.90 | -0.66 | 3298.50 |
Piramal Enterp. | 2240.15 | 44.05 | 2.01 | 3288.63 |
Ipca Labs. | 800.90 | -0.30 | -0.04 | 3193.40 |
Alembic Pharma | 519.95 | -4.30 | -0.82 | 2945.26 |
Glaxosmi. Pharma | 1329.80 | -5.80 | -0.43 | 2871.69 |
Wockhardt | 397.95 | 4.90 | 1.25 | 2477.29 |
Sanofi India | 6014.55 | 35.15 | 0.59 | 2463.60 |
Biocon | 621.65 | 3.50 | 0.57 | 2419.20 |
Quick Links for Surya Pharmaceutical:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices